Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
32.70
-0.26 (-0.79%)
At close: Jun 24, 2026, 4:00 PM EDT
32.94
+0.24 (0.73%)
After-hours: Jun 24, 2026, 6:44 PM EDT
Hims & Hers Health Employees
Hims & Hers Health had 2,442 employees as of December 31, 2025. The number of employees increased by 805 or 49.18% compared to the previous year.
Employees
2,442
Change (1Y)
805
Growth (1Y)
49.18%
Revenue / Employee
$970,406
Profits / Employee
-$5,420
Market Cap
7.57B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,442 | 805 | 49.18% |
| Dec 31, 2024 | 1,637 | 591 | 56.50% |
| Dec 31, 2023 | 1,046 | 395 | 60.68% |
| Dec 31, 2022 | 651 | 253 | 63.57% |
| Dec 31, 2021 | 398 | 217 | 119.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Viatris | 30,000 |
| Dr. Reddy's Laboratories | 27,527 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
| United Therapeutics | 1,400 |
| Lantheus Holdings | 1,193 |
HIMS News
- 6 days ago - Living Longer Is Big Business. These Stocks Will Benefit. - Barrons
- 6 days ago - Barclays Raises HIMS Stock Price Target on Strong GLP-1 Growth - TipRanks
- 7 days ago - Hims & Hers price target raised to $39 from $29 at Barclays - TheFly
- 8 days ago - Hims & Hers Stock Forecast: Leerink Analyst Sees Long-Term Peptide Upside - TipRanks
- 13 days ago - Hims & Hers Health Transcript: AGM 2026 - Transcripts
- 20 days ago - Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims - Business Wire
- 22 days ago - Hims & Hers Health Transcript: 2026 Evercore Global TMT Conference - Transcripts
- 22 days ago - Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians - Business Wire